Platinum-based chemotherapy is the standard first-line treatment for most lung cancer patients. However, the toxicity induced by platinum-based chemotherapy greatly impedes its clinical use. Previous studies showed that long non-coding RNAs (lncRNAs) with over 200 nucleotides in length affect drug response and toxicity. In the present study, we investigated the association of wellcharacterized lung cancer lncRNA polymorphisms with platinum-based chemotherapy toxicity in Chinese patients with lung cancer. A total of 467 lung cancer patients treated with platinum-based chemotherapy for at least two cycles were recruited. We primarily focused on gastrointestinal and hematological toxicities. A total of 14 potentially functional polymorphisms within 8 lncRNAs (HOTTIP, HOTAIT, H19, ANRIL, CCAT2, MALAT1, MEG3, and POLR2E) were genotyped. Unconditional logistical regression analysis was conducted to assess the associations. Gene-gene and gene-environment interactions were identified using the software generalized multifactor dimensionality reduction (GMDR). ANRIL rs1333049 was associated with severe overall toxicity in an additive model (adjusted OR=0.723, 95% CI=0.541-0.965, P=0.028). ANRIL rs1333049 was also associated with severe gastrointestinal toxicity in both the additive (adjusted OR=0.690, 95% CI=0.489-0.974, P=0.035) and dominant (adjusted OR=0.558, 95% CI=0.335-0.931, P=0.025) models. MEG3 rs116907618 was associated with severe gastrointestinal toxicity in an additive model (adjusted OR=1.717, P=0.047). GMDR identified the three-factor interaction model of POLR2E rs3787016-HOTTIP rs3807598-chemotherapy regimen as the best predictive model for hematological toxicity. In conclusion, ANRIL and MEG3 genetic polymorphisms are associated with severe platinum toxicity and could be considered as biomarkers for pretreatment evaluation in Chinese patients with lung cancer.
Introduction
Lung cancer is one of the most commonly diagnosed cancers and is the leading cause of cancer death worldwide [1] . Nonsmall cell lung cancer (NSCLC) accounts for approximately 85% of lung cancer cases. When diagnosed with lung cancer, most patients are typically in the late stages. Although significant progress in diagnosis and treatment has been made, the 5-year overall survival rate of lung cancer patients is only approximately 18% [2] . Platinum-based chemotherapy is the standard care for NSCLC patients, particularly those who are in advanced stages. However, unpredictable severe side effects, including gastrointestinal and hematologic toxicities, significantly impede the effective clinical use of platinum-based chemotherapy. The gastrointestinal toxicity, particularly severe nausea and vomiting, often results in dehydration, inappetence, malnutrition, and a reduction in treatment compliance. The main clinical symptoms of hematological toxicity include hypochromia, leukopenia, neutropenia and thrombocytopenia. According to a survey of advanced NSCLC patients, to whom a choice between supportive care and chemotherapy was presented, many would not choose chemotherapy for its likely survival benefit of 3 months but would if this treatment improved their quality of life [3] . The incidence and severity of toxicities vary greatly between individuals [4] , which suggests the need to obtain predictive markers that can identify potential chemotherapy beneficiaries with minimal toxicity.
Long non-coding RNAs (lncRNAs) are non-protein coding transcripts of over 200 nucleotides in length. Although the mechanisms of action for most of these molecules remain unknown, increasing evidence indicates that lncRNAs are important regulators in diverse biological processes, including cell growth and apoptosis. Previous studies also indicated that lncRNA expression affected drug response and toxicity [5, 6] . LncRNA NR_045623 and NR_028291 have been implicated in benzene hematoxicity [7] . In addition, single nucleotide polymorphisms (SNPs) can affect gene expression and function, partly accounting for individual differences in drug toxicity [8] . Notably, more than one-third of trait/disease-associated variants identified by genome-wide association studies were mapped to non-coding intervals [9] . Those SNPs, particularly those in lncRNAs, may affect drug toxicity.
HOTTIP, HOTAIT, H19, ANRIL, CCAT2, MALAT1, MEG3
, and POLR2E are the most studied lncRNAs involved in lung cancer tumorigenesis and drug response. In previous studies, we observed that several SNPs in those lncRNAs were associated with lung cancer susceptibility and platinum-based chemotherapy response [10] . In the present study, we evaluated the association of those SNPs with platinum-based chemotherapy toxicity in lung cancer patients.
Materials and methods
Study subjects A total of 467 lung cancer patients were enrolled in the study. All subjects were at least 18 years old and were genetically unrelated. These patients were recruited from Xiangya Hospital of Central South University (Changsha, China) or the Affiliated Cancer Hospital of Central South University (Changsha, China) between November 2011 and May 2013.
All patients were histologically or cytologically diagnosed with primary lung cancer. The details of criteria for patient recruitment and chemotherapy regimens were described elsewhere [10] . The patient charts were reviewed to extract data on the experienced toxicities. The severity of toxicity was assessed according to the National Cancer Institute Common Toxicity Criteria version 3.0 [11] . The investigators were blinded to the polymorphism status of the patients. We primarily focused on nausea, vomiting, hypochromia, leukopenia, neutropenia and thrombocytopenia. Severe gastrointestinal toxicity was grade 3 or 4 nausea and vomiting. Severe hematological toxicity included grade 3 or 4 hypochromia, leukopenia, neutropenia and thrombocytopenia. Patients who experienced any type of the grade 3 or 4 toxicities described above were defined as suffering severe overall toxicity. The study protocol was approved by the Ethics Committee of Xiangya School of Medicine, Central South University (registration CTXY-1100082 and CTXY-110008-3). We also registered in the Chinese Clinical Trial Registry (registration ChiCTR-RO-12002873 and ChiCTR-RCC-12002830).
DNA extraction, SNP selection and genotyping Genomic DNA was extracted from 5 mL venous blood using the FlexiGene DNA Kit (Qiagen, Hilden, Germany) or the Genomic DNA Purification Kit (Promega, Madison, WI, USA) following standard protocols. The DNA samples were stored at -20 °C until further use. According to the data from the HapMap database, 1000 Genomes database and previous studies, a total of 14 potentially functional SNPs or tag SNPs with minor allele frequency (MAF) >0.05 in Chinese population in 8 lncRNAs [rs1859168, rs5883064, and rs3807598 in HOXA distal transcript antisense RNA (HOTTIP); rs4759314, rs7958904 and rs1899663 in HOX transcript antisense intergenic RNA (HOTAIR); rs2839698 and rs2107425 in H19; rs10120688 and rs1333049 in CDKN2B antisense RNA 1 (ANRIL); rs6983267 in colon cancer-associated transcript 2 (CCAT2); rs619586 in metastasis-associated lung adenocarcinoma transcript 1 (MALAT1); rs116907618 in maternally expressed gene 3 (MEG3); and rs3787016 in polymerase (RNA) II subunit E (POLR2E)] were selected [10] . These polymorphisms were genotyped using the Sequenom MassARRAY System (Sequenom, San Diego, CA, USA).
Statistical analysis
All statistical analyses were performed using PASW Statistics v18.0 software (IBM Co, Armonk, NY, USA), generalized multifactor dimensionality reduction (GMDR v0.9), and PLINK 1.9 (http://pngu.mgh.harvard.edu/~purcell/plink/index.shtml). All tests were two-sided, and the criterion of statistical significance was set at P<0.05. The chi-square test was used to assess differences in proportions between groups for the categorical variables. The Hardy-Weinberg equilibrium was calculated using the chi-square test. Unconditional logistical regression analysis was conducted to calculate the odds ratio (OR) and 95% confidence interval (95% CI) with adjustments for age, sex, smoking status, stage, performance score (PS), platinum dose, chemotherapy interval, preventive treatment, the time of examining the blood for hematoxicity, histological type and chemotherapy regimen. Gene-gene and gene-environment interactions were identified using GMDR [12] . A ten-fold crossvalidation was set. Confounding factors, including age, sex, smoking status, stage, PS, platinum dose, chemotherapy interval, preventive treatment, the time of examining the blood for hematoxicity, histological type and chemotherapy regimen, were included as covariates for gene-gene interaction analysis.
Results

Patient characteristics and toxicity outcomes
All 467 subjects were cytologically or histologically confirmed NSCLC. Most of the patients were in the late stages. One hundred one (21.6%) and one hundred fourteen patients (24.4%) suffered from severe gastrointestinal and hematological toxicities, respectively. One hundred eighty-one patients (38.8%) experienced at least one type of severe toxicity ( Table  1) . Detailed information of the clinical characteristics of patients with gastrointestinal toxicity or hematologic toxicity is provided in Supplementary Table S1 and S2, respectively. Except for rs1012068, the call rates of the selected SNPs ranged from 96.1% to 100.0%. The genotype frequencies of SNPs were in Hardy-Weinberg equilibrium (Supplementary Table S3 ).
Association of lncRNA polymorphisms with severe overall toxicity Unconditional logistic regression analysis was performed to reveal the association between well-characterized lung cancer lncRNA polymorphisms and severe overall toxicity. ANRIL rs1333049 was associated with the reduced incidence of severe overall toxicity in an additive model (adjusted OR=0.723, 95% CI=0.541-0.965, P=0.028) ( Table 5) .
GMDR: genegene and geneenvironment interactions and toxicity induced by platinumbased chemotherapy GMDR was used to evaluate gene-gene interactions of 14 polymorphisms in 8 lncRNAs and overall, gastrointestinal, and hematological toxicities with adjustment for age, sex, smoking status, stage, PS, platinum dose, chemotherapy interval, preventive treatment, the time of examining the blood for hematoxicity, histological type and chemotherapy regimens.
The best predictive models of gene-gene interaction are presented in Supplementary Table S4 . However, for each model, the interaction was not significant. For the gene-environment analysis, GMDR identified the three-factor interaction model of rs3787016-rs3807598-chemotherapy regimen as the best model for hematological toxicity, with a testing balance accuracy of 0.5902, and a maximum cross-validation consistency of 9/10 (P=0.0107) (Figure 1 ). However, other best predictive models of gene-environment interaction did not reach significance (Table 6 ). 
Discussion
LncRNAs played important roles in various aspects of pathophysiological activities, such as carcinogenesis, drug resistance and toxicity. In previous studies, we explored the association of well-characterized lung cancer lncRNA genetic polymorphisms with lung cancer susceptibility and platinum-based chemotherapy response. In this study, we provided the first investigation into the association between lncRNA polymorphisms and severe toxicity induced by platinum-based chemotherapy in lung cancer patients. The results showed that ANRIL rs1333049 and rs10120688, H19 rs2107425 and HOTAIR rs7958904 were associated with the incidence of severe overall toxicity. ANRIL rs1333049 and rs10120688, H19 rs2107425 and rs2839698, HOTAIR rs1899663 and rs7958904, and MEG3 rs116907618 were associated with the risk of severe gastrointestinal or hematologic toxicity. The three-factor interaction model of POLR2E rs3787016-HOTTIP rs3807598-chemotherapy regimen was the best predictive model for hematological toxicity. ANRIL, transcribed from the INK4B-ARF-INK4A gene cluster, was overexpressed in NSCLC patient tissues and correlated with TNM stage and prognosis [13] . The knockdown of ANRIL expression impaired cell proliferation, migration and invasion, and induced cell apoptosis in esophageal cancer, gastric cancer, and lung cancer cell lines [13, 14] . ANRIL controlled the epigenetic silencing of p14ARF and p16INK4a, which were important regulators of apoptosis induced by cisplatin [15] [16] [17] . The results also revealed that ANRIL rs1333049 was associated with the incidence of severe gastrointestinal toxicity. Rs1333049, located at a hotspot region in genome wide association studies, was associated with various diseases and platinum-based chemotherapy response [10] . ANRIL rs10120688 was associated with severe hematologic toxicity. Although those SNPs were not associated with ANRIL expression, these mutations might affect the centroid secondary structure and minimum free energy of ANRIL, thereby influencing the function of ANRIL [10, 18] . H19, a paternally imprinted gene transcribed from chromosome 11p15, was maternally expressed during embryonic development, but postnatally inactivated in most tissues [19] . The overexpression of H19 was associated with the poor survival of lung cancer patients [20] . The expression of H19 could be induced by cigarette smoke condensate in human respiratory epithelial cells [21] . As an oncogene, H19 mediated cell pro- [22] . MDR1 was involved in gastrointestinal toxicity caused by platinum-based chemotherapy [23] . According to the data in Genecards (http://www.genecards.org), H19 was highly expressed in the bone marrow and stomach. Our results indicated that H19 rs2104725 and rs2839698 were associated with severe gastrointestinal toxicity, and rs2839698 was associated with severe hematologic toxicity in patients received GP regimen. Previous studies have shown that these two SNPs were associated with platinum-based chemotherapy responses. Rs2107425 did not affect the expression of H19, but might alter its secondary structure [10] . Rs2839698 was associated with serum H19 mRNA levels [24] . HOTAIR, transcribed from the human HOXC locus, was overexpressed in a plethora of cancerous tissues and associated with metastasis and prognosis [25] . HOTAIR was upregulated in cisplatin-resistant A549 cells. The overexpression of HOTAIR could lead to the cisplatin resistance in A549 cells [26] . We found that HOTAIR rs7958904 was associated with both severe gastrointestinal toxicity and hematologic toxicity. Previous studies showed that rs7958904 was associated with colorectal cancer risk and platinum-based chemotherapy responses in lung cancer and might affect the secondary structure of HOTAIR [10, 27] . Rs1899663 was associated with severe gastrointestinal toxicity in age ≥57. The SNP rs12826786 in strong linkage disequilibrium with rs1899663 (r 2 =1) was associated with HOTAIR expression [28] . MEG3, located on human chromosome 14q32, was downregulated in NSCLC tissues and correlated with pathological stage, tumor size, and prognosis [29] . MEG3 was decreased in cisplatin-resistant A549/DDP cells, and the overexpression of MEG3 increased cisplatin sensitivity by inhibiting cell proliferation and inducing apoptosis [30] . MEG3 was overexpressed in the stomach. Our findings revealed that MEG3 rs116907618 was associated with severe gastrointestinal toxicity. An RNA-fold web server predicted that the polymorphism of rs116907618 might alter the centroid secondary structure and minimum free energy of MEG3, changing the folding and function of MEG3 (Figure 2A and 2B) . However, this hypothesis needs thorough investigation.
MALAT1, transcribed from chromosome 11q13, was a predictive marker for metastasis and prognosis in several cancers, including lung cancer [31] . The silencing of MALAT1 remarkably increased the sensitivity of cancer cells to cisplatin [32] . We observed that MALAT1 rs619586 was associated with gastrointestinal toxicity. Previous studies have shown that rs619586 was associated with platinum-based chemotherapy responses and might change MALAT1 expression by affecting the transcription factor binding sites [10] . Platinum-based chemotherapy toxicities resulted from multiple genes and environmental factors, each of which might demonstrate a minor marginal effect. To further assess the combined effects, GMDR was used to explore gene-gene and gene-environment interactions. The three-factor interaction model of POLR2E rs3787016-HOTTIP rs3807598-chemotherapy regimen was the best predictive model for hematological toxicity. Rs3787016 was predicted to change the centroid secondary structure and minimum free energy of POLR2E ( Figure 2C and 2D), whereas rs3807598 might affect the transcript factor binding sites of HOTTIP (http://snpinfo.niehs.nih.gov/cgibin/snpinfo/tfbs.cgi?2_rs3807598). Studies have reported that the majority of lncRNAs were transcribed by RNA polymerase II [33] , the subunit of which could be affected by POLR2E [34] . Chemotherapy regimens were differently distributed between grade 0-2 and grade 3-4 hematological toxicity patients and observed as the best one-factor model for hematological toxicity. The results of GMDR indicated that the lncRNA POLR2E-HOTTIP-chemotherapy regimen may interact and affect hematological toxicity. However, the mechanism remains unknown.
Admittedly, the present study had some limitations. First, after FDR-BH correction at the 0.05 level [35] , rare SNPs remained significant, and the present study was conducted on a relatively small sample and should be verified on a large scale. Moreover, the functions of lncRNAs have not been widely explored. The precise mechanisms of the lncRNA SNPs in platinum-based chemotherapy toxicity remain unknown. Further studies are greatly needed. Additionally, the toxicities induced by platinum-based chemotherapy may result from multiple genetic factors. Thus, additional studies on different levels are needed.
In conclusion, ANRIL rs1333049 and rs10120688, H19 rs2107425 and rs2839698, HOTAIR rs1899663 and rs7958904, and MEG3 rs116907618 were associated with the incidence of severe gastrointestinal or hematologic toxicities. The threefactor interaction model of POLR2E rs3787016-HOTTIP rs3807598-chemotherapy regimen was the best predictive model for hematological toxicity, and these SNPs might be considered as potential predictive markers for platinum-based chemotherapy toxicity in Chinese lung cancer patients.
